UK set on resolving standoff with big pharma, science minister says
The UK is determined to resolve its standoff with the pharmaceutical industry and reverse a 10-year decline in NHS spending on medicines, the science minister has told MPs after a string of drugmakers cancelled projects worth nearly £2bn,Patrick Vallance, a former executive at drugmaker GSK, said the country needed to increase spending on medicines and reverse a decade of declining investment,“We are determined to solve this,” Lord Vallance told the Commons science committee,“This is not something [where] we’re sitting saying let’s watch the decline of the industry,That’s what’s happened for the past 10 years.
We must not do that.We have to act.Now is a pivotal moment … to try to get this right.”MPs called an emergency session in response to last week’s decision by the US drugmaker Merck, known as MSD in Europe, to scrap its plans for a £1bn London research centre and lay off 125 scientists partly based at the capital’s Francis Crick Institute.MSD blamed “the challenges of the UK not making meaningful progress towards addressing the lack of investment in the life science industry”.
AstraZeneca announced on Friday that it was putting a £200m new laboratory in Cambridge on hold,It abandoned a £450m investment in its Speke vaccine site in January after months of negotiations, citing a cut in government support,Vallance, who became a household name as chief scientific adviser during the Covid pandemic, told MPs on Tuesday that the NHS’s spending on medicines had been in decline as a proportion of total healthcare spend since 2015, but said the figure would increase from the current 9%,“The reason we need to reverse that direction is not just price,” he said,“It’s about saying we need to make sure that we get rapid uptake of the best new medicines and we have equitable access right across the UK.
”He said the UK’s drugs regulator, the Medicines and Healthcare products Regulatory Agency, and the National Institute for Health and Care Excellence, which decides which medications will be available on the NHS, needed to be linked.Dr Zubir Ahmed, the new health under-secretary and a Scottish surgeon, said the UK needed to change its pricing models in recognition of new cutting-edge treatments, which are more expensive.“We have to look at medicines in a different light … and calculate the economic and clinical benefit on that basis,” he said.Vallance said the government had not formally restarted talks with the pharmaceutical industry over its medicine pricing mechanism, which collapsed last month without an agreement and has been cited as one of the factors in drugmakers cancelling projects, but ministers were holding “lots of discussions around the commercial environment in the UK” with companies.“We cannot afford to lose this industry from the UK,” he said.
“It’s very important that we have two large global companies.That matters, that it’s two,” he said, referring to AstraZeneca and GSK.Earlier on Tuesday, MPs heard from MSD’s UK head, Ben Lucas, who said it was a “sad day that we’re leaving because we valued our collaboration with the Crick”.The company also plans to close its animal health site in Milton Keynes and transfer the work to Austria.Sign up to First EditionOur morning email breaks down the key stories of the day, telling you what’s happening and why it mattersafter newsletter promotionAstraZeneca’s UK president, Tom Keith-Roach, told MPs: “We are involved now in a highly constructive conversation with government at the highest level, notwithstanding that this is an extremely difficult moment in history and a very substantial challenge; the issue of under-investment in medicines has been a continued and worsening trend in the UK.
”The head of the Association of the British Pharmaceutical Industry, Richard Torbett, said the UK was losing out to the US, Belgium, Ireland, Singapore and Germany.GSK laid out plans on Wednesday to invest $30bn (£22bn) in research and supply chains in the US over the next five years, in an announcement timed to coincide with Donald Trump’s state visit to the UK.This includes $1.2bn of new money to build an AI-powered biologics factory in Pennsylvania that will develop treatments for the lung disease COPD and asthma, as well as cancer.GSK also reaffirmed its commitment to the UK.
Its chief executive, Emma Walmsley, said: “Here in the UK, we continue to invest in a significant manufacturing base and more than £1.5bn in R&D every year.”Keir Starmer said GSK’s US investment “will change lives on both sides of the Atlantic.“It’s a powerful example of how UK–US collaboration is driving real-world impact – improving people’s health, creating opportunity and turbocharging growth,” he said.
Labor’s Measuring What Matters is a worthy goal – but one that has utterly failed to live up to its promise | Greg Jericho
This week, the Bureau of Statistics realised its latest series of Measuring What Matters in an attempt to assess things beyond the mere economics. It comes off the back of the bureau’s first attempt to measure productivity in the non-market sector. Both raise questions of what we value and also whether our focus is where it should be.In 2020 the then shadow treasurer, Jim Chalmers, announced an ALP government would develop a wellbeing framework that would seek to “measure what matters”. It was a worthy goal mocked by the then treasurer, Josh Frydenberg
UK overall inflation remains at 3.8% in August, but food price growth climbs for fifth month in a row - as it happened
Our main story today:UK inflation held steady in August, official figures show, maintaining pressure on households as the Bank of England prepares to keep borrowing costs at elevated levels.Figures from the Office for National Statistics (ONS) show the annual rate of inflation as measured by the consumer prices index remained at 3.8% last month, the same level as July and matching the forecasts of City economists.Financial markets are widely predicting that Bank policymakers will keep interest rates on hold at 4% on Thursday amid signs of sustained inflationary pressures at almost twice its official 2% target rate.The Bank of Canada cut interest rates by a quarter point today, and the US Federal Reserve is expected to make a similar move tonight
What is new in UK-US tech deal and what will it mean for the British economy?
Donald Trump’s arrival in the UK on Tuesday night was accompanied by a multibillion-dollar transatlantic tech agreement.The announcement features some of the biggest names from Silicon Valley: the chipmaker Nvidia; the ChatGPT developer, OpenAI; and Microsoft. Big numbers were involved, with Microsoft hailing its $30bn (£22bn) investment as a major commitment to the UK – and adding, in an apparent swipe at its rivals, that it was not making “empty tech promises”.Here is a breakdown of the announcements in the UK-US “tech prosperity deal”, spelling out what is explicitly new in them.Microsoft’s president, Brad Smith, hailed the “single biggest announcement” in the pact and insisted it was not an empty promise
UK is going to be ‘AI superpower’, says Nvidia boss as he invests £500m
Jensen Huang, the co-founder and chief executive of the US AI chipmaker Nvidia, has predicted “the UK is going to be an AI superpower” as he announced a new £500m investment in a British firm.Huang, who is due to join Donald Trump at Wednesday night’s state banquet with the king, said he was taking an equity stake in NScale, a UK cloud computing company, and predicted it would earn revenues of up to £50bn over the next six years.“We’re here to announce that the UK is going to be an AI superpower,” he told a press conference in London.Huang cited as evidence of Britain’s potential its universities and several companies founded in the UK, ranging from the AI giant DeepMind to the driverless car startup Wayve. “You just don’t appreciate it
Surrey v Nottinghamshire, Sussex v Yorkshire, and more: county cricket, day three – live
Pakistan are 9 for two against UAE in their delayed Asia Cup game. It seems Pakistan initially refused to play after asking for referee Andy Pycroft to be removed. They claimed that Pycroft, the match referee for the game against India, told captain Salman Agha not to shake hands with Suryakumar Yadav at the toss.The PCB tweeted that they had asked the team to attend the game and said that Pycroft had apologised to “the manager and captain of the Pakistan cricket team.”Affection for those sitting, waiting, in The Oval stands
Salt stars in England’s four-wicket victory over Ireland in first T20 international – live reaction
Paul Stirling’s reactionThere were multiple positives to take and hopefully across the three games we can improve. We were pretty happy with 196 – but we also knew we had to get everything right in the field, and we didn’t quite manage that.We kept trying to take wickets. That’s all you can do in cricket these days – there’s no point being ultra-defensive.We’ve got a big winter ahead of us and this is the start of that
ChatGPT developing age-verification system to identify under-18 users after teen death
How memes, gaming and internet culture all relate to the Charlie Kirk shooting
How AI is undermining learning and teaching in universities | Letter
Top UK artists urge Starmer to protect their work on eve of Trump visit
‘I love you too!’ My family’s creepy, unsettling week with an AI toy
What did Elon Musk say at far-right UK rally and did his remarks break the law?